Larvol Delta - Bimekizumab-treatment-reduces-tunnels-in-patients-with-moderate-to-severe-hidradenitis-suppurativa-Pooled-1year-results-from-BE-HEARD-IampII

Bimzelx (bimekizumab-bkzx) - UCB

https://pagv3.virtual-meeting.org/eadv/eadvcongress2026/en-GB/pag/presentation/63506

Falk G. Bechara

Aug 6, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next